Table 2.
Results of linear regression models to test for gender differences in vBMD and bone size after adjusting for DXA FN aBMD and age.
Endpoint |
Parameter estimate |
P-value | Model R2 | |
---|---|---|---|---|
QCT FN total cross-sectional area | Intercept | 6.49 | <0.001 | 0.60 |
DXA FN aBMD | −0.09 | 0.852 | ||
Age | 0.01 | 0.086 | ||
Male sex | 2.62 | < 0.001 | ||
QCT FN total vBMD | Intercept | 44.41 | 0.036 | 0.73 |
DXA FN aBMD | 348.57 | <0.001 | ||
Age | −0.61 | <0.001 | ||
Male sex | −50.42 | <0.001 | ||
QCT FN trabecular vBMD | Intercept | 34.18 | 0.045 | 0.69 |
DXA FN aBMD | 242.83 | <0.001 | ||
Age | −0.76 | <0.001 | ||
Male sex | −27.90 | <0.001 | ||
QCT FN cortical vBMD | Intercept | 292.95 | <0.001 | 0.38 |
DXA FN aBMD | 315.10 | <0.001 | ||
Age | −0.41 | 0.204 | ||
Male sex | −28.65 | <0.001 |